CN110967326A - Near-infrared light-emitting binuclear ruthenium complex as tumor cell recognition and imaging reagent - Google Patents
Near-infrared light-emitting binuclear ruthenium complex as tumor cell recognition and imaging reagent Download PDFInfo
- Publication number
- CN110967326A CN110967326A CN201911274064.XA CN201911274064A CN110967326A CN 110967326 A CN110967326 A CN 110967326A CN 201911274064 A CN201911274064 A CN 201911274064A CN 110967326 A CN110967326 A CN 110967326A
- Authority
- CN
- China
- Prior art keywords
- cell
- complex
- ruthenium complex
- tumor cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004881 tumor cell Anatomy 0.000 title claims abstract description 19
- 238000003384 imaging method Methods 0.000 title claims abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 4
- 239000012327 Ruthenium complex Substances 0.000 title claims description 20
- 230000005859 cell recognition Effects 0.000 title description 2
- 210000004027 cell Anatomy 0.000 claims abstract description 38
- 239000000523 sample Substances 0.000 claims abstract description 8
- 230000027152 lysosome localization Effects 0.000 claims abstract 2
- 229910001914 chlorine tetroxide Inorganic materials 0.000 claims description 3
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims description 3
- 210000003712 lysosome Anatomy 0.000 abstract description 10
- 230000001868 lysosomic effect Effects 0.000 abstract description 9
- YAYGSLOSTXKUBW-UHFFFAOYSA-N ruthenium(2+) Chemical compound [Ru+2] YAYGSLOSTXKUBW-UHFFFAOYSA-N 0.000 abstract description 8
- 231100001083 no cytotoxicity Toxicity 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 2
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 8
- 239000007850 fluorescent dye Substances 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 6
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 4
- RUVJFMSQTCEAAB-UHFFFAOYSA-M 2-[3-[5,6-dichloro-1,3-bis[[4-(chloromethyl)phenyl]methyl]benzimidazol-2-ylidene]prop-1-enyl]-3-methyl-1,3-benzoxazol-3-ium;chloride Chemical compound [Cl-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C(N(C1=CC(Cl)=C(Cl)C=C11)CC=2C=CC(CCl)=CC=2)N1CC1=CC=C(CCl)C=C1 RUVJFMSQTCEAAB-UHFFFAOYSA-M 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 150000003303 ruthenium Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000004960 subcellular localization Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004900 autophagic degradation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 238000010226 confocal imaging Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
本发明公布了一种近红外发光的双核钌(II)配合物作为肿瘤细胞(HeLa)识别探针和溶酶体定位探针的应用。该配合物在肿瘤细胞中的荧光强度明显高于正常细胞(HEK)，可实现肿瘤细胞的识别。另外，该配合物进入细胞后，靶向定位在肿瘤细胞溶酶体，且在成像浓度条件下几乎无细胞毒，可实现长时间实时荧光监测细胞溶酶体。该配合物作为肿瘤细胞成像试剂具有极大的开发潜力。
The invention discloses the application of a near-infrared luminescent binuclear ruthenium (II) complex as a tumor cell (HeLa) identification probe and a lysosome localization probe. The fluorescence intensity of the complex in tumor cells is significantly higher than that in normal cells (HEK), which can realize the identification of tumor cells. In addition, after the complex enters the cell, it is targeted and localized in the tumor cell lysosome, and has almost no cytotoxicity under the condition of imaging concentration, which can realize long-term real-time fluorescence monitoring of the cell lysosome. The complex has great potential for development as a tumor cell imaging reagent.
Description
Technical Field
The patent belongs to the field of fluorescent biomolecular probes, and relates to application of a binuclear ruthenium complex in the related fields of tumor cell identification, lysosome positioning fluorescent probes and the like.
Background
At present, living cell imaging and biomolecular tracing become research hotspots in the fields of biomedicine, material chemistry and the like. The laser scanning confocal technology has unique optical sectioning and three-dimensional reconstruction capability, can dynamically observe cell and molecular changes in real time, and has high resolution, so the laser scanning confocal fluorescence microscope has become one of the most advanced tools for fluorescence imaging and cell research (S.A. Stricker, Microsc.Res.Techniq.,1999,6, 356-369). Compared with the traditional organic small molecule fluorescent probe, the near infrared luminescent ruthenium complex has the advantages of high adjustable ground state and excited state property, large Stokes shift, difficult photobleaching, strong biological tissue penetrability and the like, and has very wide biological fluorescent imaging application prospect (F.Tang, X.Wang, C.Yao, RSC adv.,2016,6, 77745-77751; C.S.Burke, A.Byrne, T.E.Keyes, J.Am.chem.Soc.,2018,140, 6945-6955). Malignant tumors are the "first killer" leading to the death of residents, and early diagnosis of tumors is the key to cure the tumors. The tumor cell targeting molecules can be highly aggregated in tumor cells, so that the tumor detection sensitivity is improved, and therefore, the design and synthesis of tumor targeting bioluminescence probes becomes one of the current research hotspots. However, few near-infrared luminescent ruthenium complexes with high selectivity for tumor cells are currently reported (j.li, l.zeng, chem.commun.,2019,73, 10972-.
Lysosomes are membrane saccular organelles, have weakly acidic pH (4.5-5.5), and play an important role in cell membrane repair, apoptosis, autophagy, and intracellular substance transport and metabolism (M.Ebner, A.Philipp, H.Volker, biochem. Soc.T.,2019,4, 1173-ion 1185). The labeling and tracing of the lysosome by utilizing the specific fluorescent probe has important practical significance for deeply researching the physiological function of the lysosome and diagnosing and treating related diseases.
Disclosure of Invention
The binuclear ruthenium complex fluorescent probe used in the invention is [ (bpy)2Ru(HL1)Ru(H2L2)](ClO4)4Wherein the ligand and the binuclear complex [ (bpy)2Ru(HL1)Ru(H2L2)](ClO4)4The structural formula is as follows:
the invention aims to provide application of the binuclear ruthenium complex in a tumor recognition probe.
The invention also aims to provide application of the binuclear ruthenium complex as a lysosome fluorescent probe.
Compared with the existing living cell fluorescent probe, the fluorescent probe has the beneficial effects that:
(1) the binuclear ruthenium complex has good near-infrared phosphorescence emission performance, has high selectivity on tumor cells, can realize the identification of the tumor cells by using a fluorescence imaging technology, and has great development potential in the aspects of early diagnosis and adjuvant therapy of tumors.
(2) Specifically localized to tumor cell lysosomes. Compared with the traditional lysosome fluorescent probe, the photochemical probe has stable photochemical property, almost has no cytotoxicity under the imaging concentration, can be excited by visible light, can emit light in a near infrared region, has less damage to cells compared with the ultraviolet excited cell probe, and can realize long-time cell fluorescence real-time monitoring.
Drawings
FIG. 1 is a graph showing the cell survival rate of HeLa cells incubated with different concentrations of binuclear complex after 48 h.
FIG. 2 is a confocal image and relative fluorescence intensity comparison of the binuclear ruthenium (II) complex (40. mu.M) incubated with HeLa cells and HEK293 cells for 8h, respectively.
FIG. 3 confocal images of a Co-culture model of incubated HeLa-HEK293 cells with dinuclear ruthenium (II) complex (40. mu.M) (HeLa: HEK ═ 1:1) after 8 h.
FIG. 4 is an image of confocal cells after HeLa cells incubated with binuclear ruthenium (II) complexes for 8h and co-stained with LysoTracker Green, MitoTracker Green and Hoechst 33342.
Detailed Description
Example 1: cell culture and cytotoxicity assay of binuclear ruthenium (II) complexes
CO of human cervical carcinoma HeLa cell at 37 DEG C2Cultured in an incubator (relative humidity 95%, CO)2 Content 5%), the cell culture medium is DMEM medium containing 10% fetal calf serum and 1% double antibody.
The MTT method detects the influence of the complex on the cell survival rate. Taking tumor cells in logarithmic growth phase, and obtaining the concentration of the cells at 1 × 104Wells were seeded in 96-well plates at 100 μ L per well, blank wells were filled with cell-free medium, and peripheral wells were filled with sterile PBS. IncubatorCulturing for 24h, discarding culture medium in each well, adding 100 μ L of binuclear ruthenium complex prepared from fresh culture medium with different concentrations, setting 5-6 multiple wells, and adding fresh culture medium without ruthenium complex to control group. After 48h incubation, 10. mu.L of 5mg/mL MTT solution was added to each well and incubation was continued for 4 h. Finally, 150 μ L of DMSO lysate is added to each well, after shaking for 15min, the OD value of each well at 490nm is detected by a microplate reader, and the blank control wells are zeroed. Cell viability was calculated according to the following formula:
the results of the detection are shown in FIG. 1. The concentration of the complex corresponding to 50% of inhibition rate and the IC50 value of more than 100 mu M are obtained, which shows that the binuclear ruthenium complex has lower cytotoxicity. At the imaging concentration of 40 mu M, the cell survival rate is over 80 percent, almost no cytotoxicity exists, and the influence on the cell viability is small.
Example 2: binuclear ruthenium (II) complex for recognizing tumor cells
At a cell density of 1X 104And (2) inoculating a HeLa cell and a HEK293 cell of a human embryonic kidney of a human cervical cancer into a confocal cuvette with the diameter of 20mm, culturing in an incubator for 24h, removing the old culture solution, replacing with a fresh culture medium containing 40 mu M binuclear ruthenium complex, continuously culturing for 8h, washing with a phosphate buffer solution with the pH value of 7.4 for three times, exciting with a Nikon A1R laser confocal fluorescence microscope at 562nm, and imaging with a red channel with the wavelength of 640-720 nm. The results shown in fig. 2 indicate that the binuclear ruthenium complex can be effectively taken up by tumor HeLa cells, while the human normal HEK293 cells have lower uptake rate, and the tumor cells are 13 times of the normal cells under the same experimental conditions with the fluorescence intensity. To further determine the target recognition ability of the ruthenium complex on tumor cells, a HeLa-HEK293 cell co-culture model was constructed (HeLa: HEK ═ 1:1) (fig. 3). According to the confocal imaging result, irregular oval cells with larger volume indicated by green arrows are tumor HeLa cells, slender cells indicated by white arrows are normal HEK293 cells, and the red fluorescence intensity in the HeLa cells is obviously higher than that of the HEK293 cells.
Example 3: subcellular localization of dinuclear ruthenium complexes in HeLa cells
HeLa cells were cultured at 1X 104The cell density of each well is inoculated in a 20mm confocal dish, and after 24h of culture, fresh culture medium containing 40 mu M binuclear ruthenium complex is added and incubated for 8h in an incubator. The culture medium in the dish was discarded, washed 2 times with phosphate buffer at pH 7.4, added lyso-tracker Green at 200nM, mito-tracker Green at 200nM and Hoechst33342 at 5 μ g/mL, stained for 30 minutes, washed 3 times with phosphate buffer, and observed for subcellular localization of the dinuclear ruthenium complex using Nikon A1R confocal laser fluorescence microscope. Binuclear ruthenium (II) complexes (lambda)ex＝562nm，λem640-ex＝488nm，λem＝505-530nm)，Hoechst33342(λex＝405nm，λem＝430-460nm)。
The imaging results (fig. 4) show that the red fluorescence of the binuclear ruthenium complex overlaps with the Green fluorescence of the lysosomal dye LysoTracker Green, presenting a distinct yellow color with a Pearson coefficient of 0.91, while there is almost no overlap with the Green fluorescence of the mitochondrial dye mitotracker Green and the blue fluorescence of the nuclear dye Hoechst 33342. From this, it was found that the dinuclear ruthenium (II) complex can be selectively localized in the lysosome of HeLa cells.
Claims (2)
1. An application of a binuclear ruthenium complex as a tumor cell targeted HeLa imaging reagent, wherein the binuclear ruthenium complex is [ (H)2L2)Ru(HL1)Ru(bpy)2](ClO4)4The structural formula is shown as follows:
2. the use of the dinuclear ruthenium complex according to claim 1 as a lysosome localization probe for HeLa cells.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911274064.XA CN110967326A (en) | 2019-12-12 | 2019-12-12 | Near-infrared light-emitting binuclear ruthenium complex as tumor cell recognition and imaging reagent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911274064.XA CN110967326A (en) | 2019-12-12 | 2019-12-12 | Near-infrared light-emitting binuclear ruthenium complex as tumor cell recognition and imaging reagent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110967326A true CN110967326A (en) | 2020-04-07 |
Family
ID=70033919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911274064.XA Pending CN110967326A (en) | 2019-12-12 | 2019-12-12 | Near-infrared light-emitting binuclear ruthenium complex as tumor cell recognition and imaging reagent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110967326A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116284147A (en) * | 2023-02-20 | 2023-06-23 | 青岛大学 | Fluorescent probe for selectively detecting highly expressed hNQO1 in tumor cells and its application |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101701024A (en) * | 2009-10-30 | 2010-05-05 | 暨南大学 | A kind of ruthenium complex and its preparation method and application |
| CN103509059A (en) * | 2012-12-31 | 2014-01-15 | 中山大学 | Cyclometalated ruthenium complex, and preparation method and application thereof |
| CN105062463A (en) * | 2015-07-23 | 2015-11-18 | 北京师范大学 | Applications of binuclear ruthenium complexes with different alkyl chain lengths as lysosome probe in cell |
| CN105294770A (en) * | 2015-07-23 | 2016-02-03 | 北京师范大学 | pH sensor made of near-infrared light-emitting Ru complex |
| CN106366131A (en) * | 2016-08-29 | 2017-02-01 | 北京师范大学 | Preparation method and application of physiological pH (potential of hydrogen) sensing dinuclear ruthenium complex |
| CN107118235A (en) * | 2017-05-12 | 2017-09-01 | 北京师范大学 | Application of the near-infrared luminous ruthenium complex in cellular pH sensing |
| CN110511249A (en) * | 2019-08-26 | 2019-11-29 | 北京师范大学 | Preparation and application of near-infrared luminescent ruthenium complexes |
-
2019
- 2019-12-12 CN CN201911274064.XA patent/CN110967326A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101701024A (en) * | 2009-10-30 | 2010-05-05 | 暨南大学 | A kind of ruthenium complex and its preparation method and application |
| CN103509059A (en) * | 2012-12-31 | 2014-01-15 | 中山大学 | Cyclometalated ruthenium complex, and preparation method and application thereof |
| CN105062463A (en) * | 2015-07-23 | 2015-11-18 | 北京师范大学 | Applications of binuclear ruthenium complexes with different alkyl chain lengths as lysosome probe in cell |
| CN105294770A (en) * | 2015-07-23 | 2016-02-03 | 北京师范大学 | pH sensor made of near-infrared light-emitting Ru complex |
| CN106366131A (en) * | 2016-08-29 | 2017-02-01 | 北京师范大学 | Preparation method and application of physiological pH (potential of hydrogen) sensing dinuclear ruthenium complex |
| CN107118235A (en) * | 2017-05-12 | 2017-09-01 | 北京师范大学 | Application of the near-infrared luminous ruthenium complex in cellular pH sensing |
| CN110511249A (en) * | 2019-08-26 | 2019-11-29 | 北京师范大学 | Preparation and application of near-infrared luminescent ruthenium complexes |
Non-Patent Citations (2)
| Title |
|---|
| 蓝善优等: "肿瘤微环境响应的智能纳米载体在肿瘤光动力治疗中的应用", 《中国激光》 * |
| 邱文秀等: "刺激响应型多肽的研究及其在肿瘤诊疗中的应用", 《高分子学报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116284147A (en) * | 2023-02-20 | 2023-06-23 | 青岛大学 | Fluorescent probe for selectively detecting highly expressed hNQO1 in tumor cells and its application |
| CN116284147B (en) * | 2023-02-20 | 2024-05-10 | 青岛大学 | Fluorescent probe for selective detection of hNQO1 highly expressed in tumor cells and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shen et al. | A rhodamine B-based probe for the detection of HOCl in lysosomes | |
| G. Keller et al. | Recent progress in small spirocyclic, xanthene-based fluorescent probes | |
| CN105295909A (en) | Method for using phenylenediamine and citric acid for preparing carbon quantum dot marking probe for cell developing | |
| CN112694431B (en) | Detection of Nitroreductase in Bacteria with Ultrasensitive Fluorescent Probe and Its Application in Bacterial Infection | |
| CN103122154A (en) | Organic near-infrared two-photon fluorescent dye | |
| CN106967102B (en) | A kind of enhanced fluorescence probe of hydrogen peroxide based on Rhodamine Derivatives | |
| CN112645874B (en) | Lysosome targeting fluorescent probe and preparation method and application thereof | |
| CN110982513A (en) | Preparation method of fluorescent carbon dots and application of fluorescent carbon dots in cell imaging | |
| CN109806402A (en) | A tumor-targeted fluorescent nano-strand probe, its preparation method and application | |
| Yang et al. | Red/NIR neutral BODIPY-based fluorescent probes for lighting up mitochondria | |
| Lee et al. | Label-free multiphoton imaging of microbes in root, mineral, and soil matrices with time-gated coherent Raman and fluorescence lifetime imaging | |
| CN103330948B (en) | Tumor targeted living body rapid fluorescence imaging method of rare earth metal nanocluster | |
| CN105062467B (en) | Rotor-type two-photon mitochondrion fluorescence probe and application thereof | |
| Wei et al. | Orange-emissive carbon quantum dots for ligand-directed Golgi apparatus-targeting and in vivo imaging | |
| CN118169379B (en) | Tumor drug sensitivity testing methods | |
| CN109884029A (en) | Silver/graphene quantum dot nanozyme, SERS detection kit and application | |
| CN104749369A (en) | Fluorescent labeling method for living organisms having cell membrane structures | |
| Wang et al. | Molecular engineering of a dual emission near-infrared ratiometric fluorophore for the detection of pH at the organism level | |
| CN110967326A (en) | Near-infrared light-emitting binuclear ruthenium complex as tumor cell recognition and imaging reagent | |
| CN105801562A (en) | Solid-state broadband red light emission organic light-emitting material and preparation method thereof | |
| CN103143037B (en) | Method for synthesizing rare earth metal compound nano cluster and application thereof | |
| CN103099604B (en) | An imaging method of tumor targeting based on enhancement effect of zinc ion signals | |
| CN110687087B (en) | Preparation method and application of lysosome adenosine triphosphate recognition carbon dots | |
| CN113087692A (en) | Simultaneous double-color double-targeting fluorescent probe and preparation method and application thereof | |
| CN106280533B (en) | A kind of near infrared fluorescent dye and its synthetic method and for parasite fluorescence labeling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200407 |